Diagnostics: Page 19
-
Pablo Blazquez Dominguez via Getty Images
Biden administration declares monkeypox a public health emergency
Federal health officials said Thursday that U.S. monkeypox testing capacity is at about 80,000 tests per week, although only 10% of capacity is currently being used.
By Ricky Zipp • Aug. 4, 2022 -
Permission granted by Becton Dickinson
BD’s base business growth in Q3 offset by drop in COVID-19 testing
The company reported a year-over-year drop of about $224 million in COVID-19 testing revenue compared to 2021, with the testing slowdown expected to continue.
By Ricky Zipp • Aug. 4, 2022 -
Explore the Trendline➔
Sitthiphong via Getty Images
TrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers stumbles as lockdowns, falling COVID-19 sales and rising costs hit business
Lockdowns in China caused a steep decline in equipment orders and a big setback to the firm’s core diagnostic business, even as the company expects to meet full year revenue targets.
By Nick Paul Taylor • Aug. 3, 2022 -
Ethan Miller via Getty Images
North American Diagnostics latest to recall COVID-19 tests, gets Class I label from FDA
The recall adds to a list of medtech firms that have been forced to withdraw illegally distributed COVID-19 tests, amid concerns they could yield false results.
By Ricky Zipp • Aug. 2, 2022 -
Illumina vows to fight EU efforts to block $8B Grail merger
Illumina acquired the liquid biopsy company in 2021, despite pending anti-competitiveness investigations on both sides of the Atlantic.
By Elise Reuter • Updated Aug. 2, 2022 -
Retrieved from Medridien Bioscience website on August 01, 2022
FDA reauthorizes Meridian’s COVID-19 test after changes to enable omicron detection
The renewed emergency use authorization comes as SD Biosensor works to close its $1.53 billion takeover of Meridian.
By Nick Paul Taylor • Aug. 1, 2022 -
Chip Somodevilla/Getty via Getty Images
Core diagnostic growth offsets falling COVID-19 sales at Hologic, Thermo Fisher, Qiagen
Rising demand for core diagnostics offset better-than-feared declines in COVID-19 test sales, shedding light on the companies’ post-pandemic futures.
By Nick Paul Taylor • July 29, 2022 -
Courtesy of Labcorp
Labcorp lowers forecast after Q2 slowdown, will spin off drug development unit
A drop in COVID-19 testing contributed to the company’s second quarter decline, while its base business grew by 1.2% compared to last year.
By Ricky Zipp • July 28, 2022 -
Justin Sullivan via Getty Images
MedTech Europe pushes for semiconductor prioritization as US moves to increase local supply
The trade group wants political action to stop patient harm from “a growing divergence” between semiconductor supply and demand.
By Nick Paul Taylor • July 27, 2022 -
Patrik Stollarz / Staff via Getty Images
Philips shares hit 10-year low as supply chain challenges weigh on revenue
Sleep apnea machine recall adds to woes as sales forecast is slashed for remainder of 2022.
By Elise Reuter • July 25, 2022 -
Boyloso via Getty Images
Johns Hopkins sepsis alert tool reduced patient deaths, studies find
Three prospective studies of a machine learning tool developed by a Johns Hopkins spinout found it led to earlier antibiotic treatment and reduced patient mortality.
By Elise Reuter • July 22, 2022 -
Permission granted by Mayo Clinic
Q&AFriday Q&A: Matthew Binnicker, Mayo Clinic's director of clinical virology, talks COVID-19, monkeypox testing
With cases of both viruses rising across the U.S., clinical laboratories are bringing in staff to ramp up monkeypox testing, even as demand falls for clinical diagnostics of COVID-19.
By Elise Reuter • July 22, 2022 -
Courtesy of Roche
Roche CEO Schwan, who guided company as cancer drug powerhouse, to step down next year
The drugmaker’s current diagnostics chief Thomas Schinecker will take over as CEO in March, while Schwan will seek election as chair of Roche’s board.
By Jonathan Gardner • July 21, 2022 -
Dan Zukowski/MedTech Dive
Test makers urge House, Senate to include diagnostic reforms in user-fee bill
AdvaMedDx, Abbott and Roche are among companies asking lawmakers to address the “urgent public health issue.”
By Nick Paul Taylor • July 21, 2022 -
Courtesy of Quest Diagnostics
Quest Diagnostics raises 2022 revenue forecast amid continued demand for COVID testing
The company boosted its outlook for the diagnostics unit even as the division posted a 31% decline in revenue in the second quarter.
By Ricky Zipp • July 21, 2022 -
Courtesy of Abbott
Abbott's Q2 sales boosted by COVID-19 testing; outlook for diagnostics demand remains uncertain
The company’s $2.3 billion in COVID-19 testing sales beat J.P. Morgan and Stifel analysts’ estimates by about $1 billion, while CEO Robert Ford cautioned that forecasting demand remains challenging.
By Ricky Zipp • July 20, 2022 -
Jessica McGowan/Getty Images via Getty Images
Sonic Healthcare joins CDC's monkeypox testing push to further grow capacity
Providers can order the Sonic Healthcare test as they would any other service, opening another pathway to diagnose a virus that has now infected almost 2,000 people in the U.S.
By Nick Paul Taylor • July 19, 2022 -
400tmax via Getty Images
Diagnostic sector faces a 'challenging set-up' amid economic slowdown: analysts
Goldman Sachs warned there will be “limited visibility over the course of the year,” adding that companies may need to focus more on demonstrating their paths to profitability.
By Nick Paul Taylor • July 19, 2022 -
Illumina fails to block EU antitrust review of $8B Grail merger
By siding with the European Commission, the General Court has cleared the EU to resume a review that could lead to it blocking the deal and fining Illumina.
By Nick Paul Taylor • July 18, 2022 -
Permission granted by Columbia University
Q&AFriday Q&A: Ian Lipkin, Columbia epidemiologist, talks COVID-19 testing as U.S. sees another wave
Lipkin explained why he’s not a fan of antigen tests, and stressed the need to keep PCR testing a core part of the pandemic response.
By Elise Reuter • July 15, 2022 -
Mario Tama/Getty via Getty Images
Abbott, Intuitive, J&J to kick off quarterly earnings season next week as recession threat looms
Earnings results are poised to set expectations for the impact of a potential slowdown and shed light on trends with implications for companies including Boston Scientific, Medtronic and Stryker.
By Nick Paul Taylor • July 15, 2022 -
n/a via Getty Images
Labcorp launches blood test for neurodegenerative disease biomarker
The test could detect Alzheimer’s before it manifests in routine imaging or clinical symptoms, helping physicians assess the effectiveness of treatments.
By Nick Paul Taylor • July 14, 2022 -
artJazz via Getty Images
EC publishes IVDR guidance in absence of completed Eudamed database
The commission recently announced a timeline for complete implementation of Eudamed, aiming for the second quarter of 2024.
By Ricky Zipp • July 13, 2022 -
Spencer Platt via Getty Images
Deep DiveWith COVID testing on the wane, small diagnostics companies shift focus
Startups that grew quickly from large contracts are looking nervously to a new future, as demand plummets for mass testing and shifts to homes.
By Elise Reuter • July 13, 2022 -
Pablo Blazquez Dominguez via Getty Images
Quest launches monkeypox PCR test as U.S. attempts to catch up with rising cases
The company estimates it will be able to process 30,000 tests per week by the end of July. As of July 12, there were 929 confirmed cases in the U.S., the CDC reported.
By Ricky Zipp • July 13, 2022
Previous
